Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01664026
Other study ID # PWeb123
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date August 2012
Est. completion date December 2013

Study information

Verified date January 2019
Source Clínica Bazterrica
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on:

- Weight Loss

- Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.

- Physical activity and eating habits

- Quality of life


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2013
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender All
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria:

1. Male or female 25-70 years of age

2. Obese (BMI = 30 kg/m2 and <40 kg/m2)

3. At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values >140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C =130 mg/dL and/or HDL-C <40 mg/dL and triglycerides =150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose =126 mg/dL in two consecutive office visits

4. Participant must be willing and able to provide written informed consent

5. Participant must be willing and able to comply with study related procedures

6. Participant must have access to Internet and e-mail

Exclusion Criteria:

1. Stage 1 or 2 on Patient Activation Measures tool

2. Weight change of more than 5 kg during the 3 months preceding the screening visit

3. History of bariatric surgery

4. Fasting Plasma Glucose at screening > 250 mg/dL (> 13.9 mmol/L)

5. Hemoglobin A1c at screening >8.5%

6. Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months)

7. Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure >160/100 mmHg

8. Secondary hypertension

9. Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit

10. Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke

11. Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult.

12. Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study

13. Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer

14. Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening

15. Use of any investigational agent (drug, biologic, device) within 3 months prior to screening

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Web-based lifestyle modification
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
Web-based lifestyle modification +
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.

Locations

Country Name City State
Argentina Clinica Bazterrica Buenos Aires

Sponsors (1)

Lead Sponsor Collaborator
Clínica Bazterrica

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes in lifestyle behaviors (physical activity and eating habits) 6 months
Other Changes in quality of life 6 months
Primary Change in body weight from randomization to 6 months 6 months
Secondary Changes in waist circumference 6 months
Secondary Changes in blood pressure 6 months
Secondary Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol) 6 months
Secondary Changes in glycemic parameters (glucose and hemoglobin A1c) 6 months
Secondary Changes in C-reactive protein 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2